Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02025010
Title Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates.
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Abiraterone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Memorial Sloan Kettering Cancer Center Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Cancer Center Commack Commack New York 11725 United States Details
Memorial Sloan Kettering Cancer Center West Harrison Harrison New York 10604 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center Rockville Centre Rockville Centre New York 11510 United States Details
Memorial Sloan Kettering Cancer Center Sleepy Hollow Sleepy Hollow New York 10591 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field